🔓 Unlock the full profile of Errik Anderson (Alloy Therapeutics, Inc.), including verified contact details, financial insights, and professional associations.
See Errik Anderson Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: err*****@all******.com
Mobile: 85878*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Errik Anderson is the CEO, Chairman, and Founder of Alloy Therapeutics, Inc., a biopharmaceutical company established in 2017 with a focus on enabling the next generation of therapies.
- Alloy Therapeutics aims to transform the field of therapeutic development by creating a unique platform that enhances the efficiency of antibody drug discovery.
- Under Anderson's leadership, the company has experienced significant growth, with a reported 21% increase in headcount over twelve months.
- Anderson also serves as Managing Partner at 82VS, contributing to investment strategies and portfolio management since 2017.
- In 2014, Anderson became a Director and Investor at Alumni Ventures, helping to shape early-stage investments in various sectors.
- As a Co-Founder and Owner of the New England Free Jacks since 2018, Anderson is involved in the promotion and development of rugby in the region.
- Prior to these roles, Anderson was the Founder and Managing Partner at Ulysses Diversified Holdings, demonstrating a strong background in investment and management.
- Alloy Therapeutics is recognized for its innovative approaches and collaborative spirit in navigating the challenges of biopharmaceuticals, further enhancing its reputation under Anderson's guidance.